Method for treating mycosis using imidazolylacetonitrile derivat

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514397, A61K 31415, C07D23900, C07D40906, C07D23300

Patent

active

059004886

ABSTRACT:
rile, tonitrile, and pharmaceutically acceptable salts thereof which can be used as a pharmaceutical agent are disclosed. A process for producing them and a method for treating mycoses using them are also disclosed.

REFERENCES:
patent: 4636519 (1987-01-01), Seo et al.
Database WPI, Week 9051, Derwent Publications Ltd., London, GB & JP, A, 02 275 877 (Nihon Noyaku KK), 9 Nov. 1990.
Arzneimittelforschung, vol. 42, No. 3, 1992, pp. 345-349, H. Oka et al.: "Therapeutic Efficacy of Latoconazole in Formulations of Clinical Use on Experimental Dermatophytosis in Guinea Pigs."
Antimicrob. Agents Chemother., vol. 38, No. 9, 1994, pp. 2204-2206, Y. Niwano et al.: "Therapeutic Efficacy of Latoconazole, a New Imidazole Antimycotic Agent, for Experimental Cutaneous Candidiasis in Guinea Pigs."
Arzneimittelforschung, vol. 41, No. 8, 1991, pp. 847-851, T. Ohmi et al.: "Antifungal Activity of the new Agent Latoconazole in Two Tinea Models."

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating mycosis using imidazolylacetonitrile derivat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating mycosis using imidazolylacetonitrile derivat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating mycosis using imidazolylacetonitrile derivat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1870031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.